Highlights of AbbVie’s Q1 2024 financial results
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and...
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and...
Veru Inc (NASDAQ:VERU) Q2 2023 Earnings Call dated May. 11, 2023. Corporate Participants: Samuel Fisch — Executive Director of Investor Relations and...
PetIQ, inc (NASDAQ: PETQ) Q1 2023 Earnings Call dated May. 09, 2023 Corporate Participants: Katie Turner — Investor Relations Cord...
Merck & Co., Inc. (NYSE: MRK) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Peter Dannenbaum — Vice President, Investor...
RVL Pharmaceuticals plc (NASDAQ: RVLP) Q4 2022 earnings call dated Mar. 20, 2023 Corporate Participants: Lisa Wilson — Investor Relations Brian Markison — Chief...
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Atabak Mokari — Chief Financial Officer Charles Robb — Chief...
PetIQ Inc (NASDAQ:PETQ) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Katie Turner — Investor Relations McCord Christensen — Chief Executive Officer...
Moderna Inc (NASDAQ:MRNA) Q4 2022 Earnings Call dated Feb. 23, 2023. Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane Bancel — Chief...
Merck & Co Inc (NYSE:MRK) Q4 2022 Earnings Call dated Feb. 02, 2023. Corporate Participants: Peter Dannenbaum — Vice President, Investor Relations...